Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders
Authors:
- A FerrettiAFA Ferretti
- A NicoliniA Nicolini
- A CarpiACA Carpi
- 1 January 1996
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 50 (8) , 376-382
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factorsBritish Journal of Haematology, 1993
- Essential thrombocythemia. Clinical characteristics and course of 61 casesCancer, 1988
- Anagrelide: A New Drug for Treating ThrombocytosisNew England Journal of Medicine, 1988
- Essential thrombocythemias. Clinical evolutionary and biological dataCancer, 1986
- Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and functionEuropean Journal of Cancer and Clinical Oncology, 1983
- Deficiency of Platelet Lipoxygenase Activity in Myeloproliferative DisordersNew England Journal of Medicine, 1982
- Arterial thrombosis in essential thrombocythemiaAmerican Heart Journal, 1978
- Microvascular Occlusive Lesions in Primary ThrombocythaemiaBritish Journal of Haematology, 1977
- Essential Thrombocythaemia and Peripheral GangreneBMJ, 1974
- Complications and Causes of Death in Polycythaemia VeraActa Medica Scandinavica, 1962